MBX MBX Biosciences, Inc.
Company Analysis
Latest News
🟢 MBX Biosciences is trading 4.18% up today amid biotech-sector and broader-market gains
MBX Biosciences is trading at $52.39, up 4.18%, with biotech-sector and broader-market strength as a possible backdrop. - No clear company-specific...
🟢 MBX Biosciences is trading 4.1% up today with broader-market gains offering a possible backdrop
MBX Biosciences is trading at $50.48, up 4.09%, with broader-market gains offering a possible backdrop; a direct link is unconfirmed. - The S&P 500 and Nasdaq...
🔴 MBX Biosciences is trading 5% down today amid broader market and biotech weakness
MBX Biosciences is trading at $47.84, down 5.19%, with broader risk-off sentiment the likeliest context for the decline. - No clear company-specific news...
🔴 MBX Biosciences is trading 4.32% down today amid S&P 500 and Nasdaq declines
MBX Biosciences is trading at $51.60, down 4.32%, with broad market weakness the likeliest context; no clear company-specific catalyst was identified. -...
🟢 MBX Biosciences is trading 4.3% up today amid positive biotech-sector sentiment
MBX Biosciences is trading 4.26% up now at $55.78, with positive biotech sentiment the likeliest context for the move. - The share move is on October 21,...
🟢 MBX Biosciences is trading 4.3% up today amid stronger biotech-sector sentiment
MBX Biosciences is trading at $54.74, up 4.31% on October 20, 2026; stronger biotech-sector sentiment is the likeliest explanation, though evidence does not...
🟢 MBX Biosciences is trading 5% up with no specific same-day catalyst identified
MBX Biosciences is trading at $52.11, up 5.04%, with no specific same-day company catalyst identified. - No October 19 announcement appears in the company’s...
🟢 MBX Biosciences is trading 4.66% up on October 15, 2026, as biotech sector rises 2.20%
MBX Biosciences is trading 4.66% higher at $51.09 on October 15, 2026, with the biotech sector’s 2.20% gain providing relevant market context; no clear...
🔴 MBX Biosciences is trading 4.08% down in pre-market with no clear company-specific catalyst
MBX Biosciences is trading at $47.00, down 4.08% in pre-market, with no clear company-specific announcement explaining the decline. - On October 13, MBX...
🔴 MBX Biosciences is trading 4.3% down today amid biotech-sector weakness
MBX Biosciences is trading 4.33% lower at $49.77, with no clear company-specific news explaining the October 13 decline. - The company announced upcoming...
🔴 MBX Biosciences is trading 4.66% down today amid biotech-sector and broader market pressure
MBX Biosciences is trading at $52.00, down 4.66%, amid biotech-sector and broader market pressure. - During the October 8 session, no new company-specific...
🔴 MBX Biosciences is trading 4.55% down today amid rising Treasury yields
MBX Biosciences is trading 4.55% lower at $54.33, amid pressure on biotech stocks as Treasury yields rose above 5.3%. - Investors were awaiting Federal Reserve...
🔴 MBX Biosciences is trading 4.22% down as biotech stocks weaken
MBX Biosciences is trading 4.22% lower at $56.07, with biotech-sector weakness the likeliest explanation. - On October 6, 2026, XBI was down 2.50%, while...
MBX Biosciences Gets $150 Target on Obesity Drug Potential
Guggenheim maintained its Buy rating on MBX Biosciences. The firm raised its price target from $88 to $150. MBX shares were trading at $56.55. The new target...
🟢 MBX Biosciences is trading 5% up with no clear company-specific catalyst identified
MBX Biosciences is trading at $59.28, up 4.83%, with no clear company-specific catalyst identified. - No company-specific announcement explaining the October...
🟢 MBX Biosciences is trading 4.18% up with no clear catalyst identified
On September 28, 2026, MBX Biosciences is trading 4.18% higher at $55.87, with no confirmed catalyst identified. - The company’s investor-relations release...
🔴 MBX Biosciences is trading 4.08% down today as catalyst remains unconfirmed
MBX Biosciences is trading 4.08% lower at $53.13; no specific catalyst for the September 25, 2026 decline has been identified. - No new company-specific...
🔴 MBX Biosciences is trading 4.37% down today amid a 19-year-high 10-year Treasury yield
MBX Biosciences is trading 4.37% lower at $55.36 as broader risk-off pressure weighs on biotechnology and growth stocks. - The Nasdaq is down 0.87%, while...
🔴 MBX Biosciences is trading 4.3% down today
MBX Biosciences is trading 4.3% lower at $59.32, with no confirmed company-specific announcement identified for September 23, 2026. - Its investor-relations...
🟢 MBX Biosciences is trading 4.3% up in pre-market; reason remains unconfirmed
MBX Biosciences is trading at $63.53 (+4.25%) in pre-market on September 22, 2026; the reason remains unconfirmed. - Recent coverage centers on the September...